Supernus Pharmaceuticals Inc. is the fifth company to get cited by FDA this year for a misleading drug promotion, and while the criticism is typical the context is somewhat unusual.
The agency’s Office of Prescription and Promotion (OPDP) objected to a Key Opinion Leader Spanish video for Supernus’ seizure drug...